ACQUISITION OF REAGENTS FOR THE IMMUNOCHEMISTRY LABORATORY WITH EQUIPMENT ON LOAN

This public tender, identified as LP-SM-15-2025-INEN-1, is being issued by the National Institute of Neoplastic Diseases (Instituto Nacional de Enfermedades Neoplásicas - INEN), located in Lima, Peru. The primary objective of this procurement process is the acquisition of reagents essential for the operation of the Immuno-chemistry Laboratory. A key aspect of this tender is that the associated equipment will be provided on a loan basis (comodato), meaning the successful bidder will supply the reagents, and the necessary equipment will be made available to the laboratory without direct purchase by INEN. This arrangement suggests a need for suppliers who can offer comprehensive solutions, including reagent supply and equipment provision under a loan agreement. The contracting method is a Public Tender (Licitación Pública), indicating a formal and competitive bidding process designed to ensure transparency and value for money. Interested parties are expected to meet specific technical and financial requirements to be considered. The tender focuses on ensuring the continued and efficient functioning of the Immuno-chemistry Laboratory, which is critical for diagnostic and research activities within the National Institute of Neoplastic Diseases. Further details regarding the specific types of reagents, equipment specifications, delivery terms, and evaluation criteria will be outlined in the full tender documentation.

This is a supplies contract in the general supplies sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 46.3 million.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.